Literature DB >> 22113756

Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway.

Jian-Jun Chen1, Sheng-Hua Zhou.   

Abstract

BACKGROUND: This study was designed to examine whether transplantation of mesenchymal stem cells (MSCs) overexpressing miR-126 enhances angiogenesis in the infarcted myocardium of mice.
METHODS: MSCs were harvested from mice using density gradient centrifugation and adherent culture. MSCs were transfected with lentiviral vectors carrying mature miR-126. Mice models of myocardial infarction were established by ligation of coronary artery. The ligated animals were randomly divided into three groups (15 in each) and after two weeks, were intramyocardially injected at the heart infarct zone with miR-126-transfected MSCs (the miR-126-MSCs group), MSCs (the MSCs group), or medium (the PBS group). Six weeks later, histological study and echocardiographic assessment were performed.
RESULTS: Capillary density of the infarcted region was significantly improved in the miR-126- MSCs group compared to the MSC group and the PBS group (both p < 0.01). Western blot showed that ERK(1), pERK(1), AKT and pAKT gene were dramatically enhanced in the miR-126-MSC group compared to the MSC group and the PBS group (both p < 0.05). Echocardiography showed MiR-126 led to a sustained improvement in cardiac function for at least six weeks at the injected area, as assessed by left ventricular ejection fraction and fraction of shortening.
CONCLUSIONS: Transplantation of MSCs transfected with miR-126 can improve angiogenesis and cardiac function in the infarcted area of the hearts of mice, which may be due to stimulation of the AKT/ERK-related pathway.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22113756     DOI: 10.5603/cj.2011.0032

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  48 in total

Review 1.  Cardiac cell therapy: boosting mesenchymal stem cells effects.

Authors:  E Samper; A Diez-Juan; J A Montero; P Sepúlveda
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

2.  MiR-126a-5p is involved in the hypoxia-induced endothelial-to-mesenchymal transition of neonatal pulmonary hypertension.

Authors:  Yan-Ping Xu; Qi He; Zheng Shen; Xiao-Li Shu; Chen-Hong Wang; Jia-Jun Zhu; Li-Ping Shi; Li-Zhong Du
Journal:  Hypertens Res       Date:  2017-02-02       Impact factor: 3.872

Review 3.  Developing miRNA therapeutics for cardiac repair in ischemic heart disease.

Authors:  Kai Zhu; Dingqian Liu; Hao Lai; Jun Li; Chunsheng Wang
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

4.  Adipose-derived stem cell-derived microvesicle-released miR-210 promoted proliferation, migration and invasion of endothelial cells by regulating RUNX3.

Authors:  Zeqi Zheng; Lijuan Liu; Yuliang Zhan; Songping Yu; Ting Kang
Journal:  Cell Cycle       Date:  2018-07-05       Impact factor: 4.534

Review 5.  MicroRNA networks in regulatory T cells.

Authors:  Xuehua Tang; Ruijing Tang; Yujun Xu; Qingling Wang; Yayi Hou; Sunan Shen; Tingting Wang
Journal:  J Physiol Biochem       Date:  2014-08-10       Impact factor: 4.158

Review 6.  New strategies for improving stem cell therapy in ischemic heart disease.

Authors:  Peisen Huang; Xiaqiu Tian; Qing Li; Yuejin Yang
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

7.  Is the regulation of SIRT1 by miRNA-34a the key to mesenchymal stem cell survival?

Authors:  Michael A Bellio; Wayne Balkan; Joshua M Hare; Ivonne Hernandez Schulman
Journal:  Ann Transl Med       Date:  2016-06

Review 8.  MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine.

Authors:  V Sala; S Bergerone; S Gatti; S Gallo; A Ponzetto; C Ponzetto; T Crepaldi
Journal:  Cell Mol Life Sci       Date:  2013-11-12       Impact factor: 9.261

9.  The effects of microvesicles on endothelial progenitor cells are compromised in type 2 diabetic patients via downregulation of the miR-126/VEGFR2 pathway.

Authors:  Keng Wu; Yi Yang; Yun Zhong; Hala Mustafa Ammar; Peihua Zhang; Runmin Guo; Hua Liu; Chuanfang Cheng; Thomas M Koroscil; Yanfang Chen; Shiming Liu; Ji C Bihl
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-03-08       Impact factor: 4.310

10.  Cross talk of combined gene and cell therapy in ischemic heart disease: role of exosomal microRNA transfer.

Authors:  Sang-Ging Ong; Won Hee Lee; Mei Huang; Devaveena Dey; Kazuki Kodo; Veronica Sanchez-Freire; Joseph D Gold; Joseph C Wu
Journal:  Circulation       Date:  2014-09-09       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.